Abstract
Background and Objectives
There is little evidence in the literature about the possible relationship between sarcopenia and cognition in older adults. Our objective was to investigate the association between cognitive impairment and sarcopenia in older adults living in the community through a systematic review of published studies.
Research Design and Methods
We performed a systematic review with meta-analysis through Pubmed, LILACS, Scielo and Web of Science databases between March 1, 2001 and December 18, 2018. We included longitudinal and cross-sectional studies that evaluated sarcopenia and cognition as a primary objective.
Results
Of the 274 studies identified by the systematic review, 10 were included in qualitative analysis (total of 9,703 participants), and 6 were eligible for the meta-analysis (n = 7,045). Mean prevalence of sarcopenia was 10.5%. Cognitive impairment was observed in 269 participants with sarcopenia (40%), compared with 1,616 in non-sarcopenic participants (25.3%). Sarcopenia was significantly associated with cognitive impairment (pooled OR = 2.50, 95% CI = 1.26–4.92; p = 0.008). Heterogeneity across the studies was high and significant (I2 = 84%).
Discussion and Implications
Our analyzes confirmed that sarcopenic older adults presented a higher prevalence of cognitive impairment. Sarcopenia may represent a risk factor for cognitive decline, but longitudinal studies are needed to explore causality.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12603-019-1188-8/MediaObjects/12603_2019_1188_Fig1_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12603-019-1188-8/MediaObjects/12603_2019_1188_Fig2_HTML.jpg)
Similar content being viewed by others
![](https://media.springernature.com/w215h120/springer-static/image/art%3A10.1007%2Fs40279-023-01870-9/MediaObjects/40279_2023_1870_Fig1_HTML.png)
Change history
06 July 2019
The authors from «Sarcopenia Is Associated with Cognitive Impairment in Older Adults: A Systematic Review and Meta-Analysis”, J Nutr Health Aging. 2019;23(6):525–531, advise an error in Figure 2. Where is stated Association not present in the bottom of the Forest Plot is in fact Association present, and vice-versa. Positive associations are indicated at the right side of the Forest Plot.
References
Cesari M, Rolland Y, Van Kan GA, Bandinelli S, Vellas B, Ferrucci L. Sarcopenia-related parameters and incident disability in older persons: Results from the “Invecchiare in Chianti” study. J Gerontol A Biol Sci Med Sci. 2015; 70(4):457–63. doi: https://doi.org/10.1093/gerona/glu181.
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing. 2010; 39(4):412–23. doi: https://doi.org/10.1093/ageing/afq034
Arango-Lopera VE, Arroyo P, Gutiérrez-Robledo LM, Pérez-Zepeda MU, Cesari M. Mortality as an adverse outcome of sarcopenia. J Nutr Health Aging. 2013; 17(3): 259–262. doi: https://doi.org/10.1007/s12603-012-0434-0
Landi F, Cruz-Jentoft AJ, Liperoti R, Russo A, Giovannini S, Tosato M, et al. Sarcopenia and mortality risk in frail olderpersons aged 80 years and older: Results from iLSIRENTE study. Age Ageing. 2013; 42(2):203–9. doi: https://doi.org/10.1093/ageing/afs194.
Janssen I, Shepard ÃDS, Katzmarzyk PT, Roubenoff R, Mhs Ã. The Healthcare Costs of Sarcopenia in the United States. J Am Geriatr Soc. 2004; 52(1):80–5. https://doi.org/10.1111/j.1532-5415.2004.52014.x
Dent E, Morley JE, Cruz-Jentoft AJ, et al. International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, diagnosis and management. J Nutr Health Aging 2018 (In press).
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019; 48(1):16–31. doi: https://doi.org/10.1093/ageing/afy169.
Diz JBM, Leopoldino AAO, Moreira B de S, Henschke N, Dias RC, Pereira LSM, et al. Prevalence of sarcopenia in older Brazilians: A systematic review and meta-analysis. Geriatr Gerontol Int. 2017; 17(1):5–16. doi: https://doi.org/10.1111/ggi.12720
Chang K-V, Hsu T-H, Wu W-T, Huang K-C, Han D-S. Association Between Sarcopenia and Cognitive Impairment: A Systematic Review and Meta-Analysis. J Am Med Dir Assoc. 2016; 17(12):1164.e7–1164.e15. doi: https://doi.org/10.1016/j.jamda.2016.09.013.
Alexandre T da S, Duarte YA de O, Santos JLF, Wong R, Lebrão ML. Prevalence and associated factors of sarcopenia among elderly in Brazil: findings from the SABE study. J Nutr Health Aging. 2014; 18(3):284–90. doi: https://doi.org/10.1007/s12603-013-0413-0.
Sugimoto T, Ono R, Murata S, Saji N, Matsui Y, Niida S, et al. Prevalence and associated factors of sarcopenia in elderly subjects with amnestic mild cognitive impairment or Alzheimer disease. Curr Alzheimer Res. 2016; 13(6):718–26. doi: https://doi.org/10.2174/1567205013666160211124828
Samper-Ternent R, Reyes-Ortiz C, Ottenbacher KJ, Cano CA. Frailty and sarcopenia in Bogotá: results from the SABE Bogotá Study. Aging Clin Exp Res. 2017; 29(2):265–272. doi: https://doi.org/10.1007/s40520-016-0561-2
Van Kan GA, Cesari M, Gillette-Guyonnet S, Dupuy C, Nourhashémi F, Schott AM, et al. Sarcopenia and cognitive impairment in elderly women: Results from the EPIDOS cohort. Age Ageing. 2013; 42(2):196–202. doi: https://doi.org/10.1093/ageing/afs173
Papachristou E, Ramsay SE, Lennon LT, Papacosta O, Iliffe S, Whincup PH, et al. The relationships between body composition characteristics and cognitive functioning in a population-based sample of older British men. BMC Geriatr. 2015; 15:172. doi: https://doi.org/10.1186/s12877-015-0169-y.
Nishiguchi S, Yamada M, Fukutani N, Adachi D, Tashiro Y, Hotta T, et al. Differential association of frailty with cognitive decline and sarcopenia in community-dwelling older adults. J Am Med Dir Assoc. 2015; 16(2):120–4. doi: https://doi.org/10.1016/j.jamda.2014.07.010.
Nishiguchi S, Yamada M, Shirooka H, Nozaki Y, Fukutani N, Tashiro Y, et al. Sarcopenia as a Risk Factor for Cognitive Deterioration in Community-Dwelling Older Adults: A 1-Year Prospective Study. J Am Med Dir Assoc. 2016; 17(4):372.e5–8. doi: https://doi.org/10.1016/j.jamda.2015.12.096
Gao L, Jiang J, Yang M, Hao Q, Luo L, Dong B. Prevalence of Sarcopenia and Associated Factors in Chinese Community-Dwelling Elderly: Comparison Between Rural and Urban Areas. J Am Med Dir Assoc. 2015; 16(11):1003.e1–6. doi: https://doi.org/10.1016/j.jamda.2015.07.020.
Ogawa Y, Kaneko Y, Sato T, Shimizu S, Kanetaka H, Hanyu H. Sarcopenia and Muscle Functions at Various Stages of Alzheimer Disease. Front Neurol. 2018; 9: 710. doi: https://doi.org/10.3389/fneur.2018.00710
Huang C-Y, Hwang A-C, Liu L-K, Lee W-J, Chen L-Y, Peng L-N, et al. Association of Dynapenia, Sarcopenia, and Cognitive Impairment Among Community-Dwelling Older Taiwanese. Rejuvenation Res. 2016; 19(1):71–8. doi: https://doi.org/10.1089/rej.2015.1710
Lee I, Cho J, Hong H, ** Y, Kim D, Kang H. Sarcopenia Is Associated with Cognitive Impairment and Depression in Elderly Korean Women. Iran J Public Health. 2018; 47(3): 327–334.
Petersson S, Philippou E. The effects of Mediterranean Diet on cognitive function and dementia: Systematic review of the evidence. Adv Nutr. 2016; 7(5):889–904. doi: https://doi.org/10.3945/an.116.012138
Nieuwenhuizen WF, Weenen H, Rigby P, Hetherington MM. Older adults and patients in need of nutritional support: Review of current treatment options and factors influencing nutritional intake. Clin Nutr. 2010; 29(2):160–9. doi: https://doi.org/10.1016/j.clnu.2009.09.003
Ishii H, Makizako H, Doi T, Tsutsumimoto K, Shimada H. Associations of Skeletal Muscle Mass, Lower-Extremity Functioning, and Cognitive Impairment in Community-Dwelling Older People in Japan. J Nutr Health Aging (2019) 23: 35. doi: https://doi.org/10.1007/s12603-018-1110-9
Brach JS, FitzGerald S, Newman AB, Kelsey S, Kuller L, VanSwearingen JM, et al. Physical Activity and Functional Status in Community-Dwelling Older Women. Arch Intern Med. 2003; 163(21):2565–71. doi: https://doi.org/10.1001/archinte.163.21.2565
Alfaro-Acha A, Al Snih S, Raji MA, Markides KS, Ottenbacher KJ. Does 8-foot walk time predict cognitive decline in older Mexicans Americans? J Am Geriatr Soc. 2007; 55(2):245–51. doi: https://doi.org/10.1111/j.1532-5415.2007.01039.x
Alfaro-Acha A, Al Snih S, Raji MA, Kuo Y-F, Professor A, Markides KS, et al. Handgrip Strength and Cognitive Decline in Older Mexican Americans. J Gerontol A Biol Sci Med Sci. 2006; 61(8):859–65.
Kang H, Schuman EM. Long-Lasting. Neurotrophin-Induced Enhancement of Synaptic Transmission in the Adult Hippocampus. Science. 1995; 267(5204):1658–62. doi: https://doi.org/10.1126/science.7886457
Dam PS Van, Aleman A, Vries WR De, Deijen JB, Veen EA Van Der, Haan F De, et al. Growth hormone, insulin-like growth factor I and cognitive function in adults. Growth Horm IGF Res. 2000; 10 Suppl B:S69–73. doi: https://doi.org/10.1016/S1096-6374(00)80013-1
Erickson KI, Voss MW, Shaurya R, Basak C, Szabo A. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci U S A. 2011; 108(7):3017–22. doi: https://doi.org/10.1073/pnas.1015950108.
Ardawi MSM, Rouzi AA, Qari MH. Physical activity in relation to serum sclerostin, insulin-like growth factor-1, and bone turnover markers in healthy premenopausal women: A cross-sectional and a longitudinal study. J Clin Endocrinol Metab. 2012; 97(10):3691–9. doi: https://doi.org/10.1210/jc.2011-3361
Morley JE. Editorial: Bidirectional Communication Between Brain and Muscle. J Nutr Health Aging. 2018; 22(10):1144–1145. doi: https://doi.org/10.1007/s12603-018-1141-2.
Acknowledgement
Prof. Aprahamian receives National public grant level 2 from the National Council for Scientific and Technological Development (Ministry of Science, Technology, Innovation and Communications, Brazil).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cabett Cipolli, G., Sanches Yassuda, M. & Aprahamian, I. Sarcopenia Is Associated with Cognitive Impairment in Older Adults: A Systematic Review and Meta-Analysis. J Nutr Health Aging 23, 525–531 (2019). https://doi.org/10.1007/s12603-019-1188-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-019-1188-8